Health: Eli Lilly to offer early access to next-gen obesity drug to some patients
Kort samengevat
Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its US FDA approval.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Gdnonline.
Lees het volledige bericht ↗